Clene (CLNN) vs FitLife Brands (FTLF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
FitLife Brands (FTLF) has outperformed Clene (CLNN) over the past year, losing 58.1% versus a loss of 58.8%. Over five years, FTLF leads with a +26.1% price change compared with -96.9% for CLNN. FitLife Brands is the larger company by market cap ($81.7 million vs $55.2 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLNN | FTLF |
|---|---|---|
| Share price | $3.88 | $8.70 |
| Market cap | $55.15M | $81.70M |
| 1-day change | -1.02% | -5.74% |
| YTD return | -33.90% | -46.53% |
| 1-year return | -58.81% | -58.09% |
| 5-year return | -96.86% | +26.09% |
| P/E ratio (TTM) | — | 14.03 |
| Forward P/E | — | 6.74 |
| EPS (TTM) | $-3.52 | $0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $20.98 |
| 52-week low | $3.25 | $8.51 |
| Distance from 52-week high | -71.26% | -58.53% |
| Analyst consensus | none | none |
| Avg. price target upside | +729.90% | +101.15% |
| Average volume | 100.21K | 11.75K |
| Shares outstanding | 14.21M | 9.39M |
| Employees | 76 | 81 |
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Packaged Foods | Packaged Foods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Clene
CLNN stock →Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.
Consumer Defensive · Packaged Foods · 76 employees
About FitLife Brands
FTLF stock →FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally.
Consumer Defensive · Packaged Foods · 81 employees
CLNN vs FTLF FAQ
Which is bigger, Clene or FitLife Brands?
FitLife Brands (FTLF) is larger, with a market capitalization of $81.70M compared with $55.15M for Clene (CLNN).
Which stock has performed better over the past year, CLNN or FTLF?
FTLF returned -58.09% over the past 12 months, compared with -58.81% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are Clene and FitLife Brands in the same industry?
Yes. Both are classified in the Packaged Foods industry within the Consumer Defensive sector.